AlphaStocks
4.4
Weak

Cencora, Inc. (COR)

Health Care / Health Care Distributors

S&P 500

$252.67

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#739out of 1126 in Health Care

Is Cencora, Inc. a Good Investment in 2026?

Cencora, Inc. (COR) scores 4.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates Cencora, Inc. as Strong. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 65%). Cencora, Inc. currently trades above its estimated fair value of $197, suggesting limited upside at current prices. Cencora, Inc. ranks #739 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E31.7ROE89.1Market Cap49BDiv Yield0.9

Estimated Fair Value

$197.1228% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

Significantly above fair value

Lynch

Neutral

PEG 2.8 · Stalwart

Greenblatt

Caution

Bottom half (rank 65%)

Frequently Asked Questions

Is Cencora, Inc. (COR) a good investment?
Based on AlphaStocks' composite analysis, Cencora, Inc. (COR) scores 4.4 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading slightly above estimated fair value.
What is Cencora, Inc.'s Piotroski F-Score?
Cencora, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is COR overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $197, COR appears overvalued. The stock currently trades 28% above its estimated fair value. Trading slightly above estimated fair value.
How does COR compare to other Health Care stocks?
Cencora, Inc. ranks #739 out of 1126 stocks in the Health Care sector, placing it in the top 66% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about COR?
AlphaStocks evaluates COR using five proven investment models. Piotroski: Attractive; Buffett: Strong; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.4/10.

Similar Stocks

Compare COR with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer